Microbot Medical (MBOT) Change in Cash (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Change in Cash data on file, last reported at -$56000.0 in Q1 2026.

• Quarterly Change in Cash fell 154.9% year-over-year to -$56000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $652000.0 (down 68.27% YoY) and the FY2025 annual result came in at $810000.0, up 25.39% from the prior year.
• Change in Cash climbed to -$56000.0 in Q1 2026, from -$2.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.6 million in Q2 2023 to a low of -$4.4 million in Q3 2023.
• A 5-year average of -$568411.8 and a median of -$320000.0 in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash sank 2882.35% — and 2025, when it soared 232.07%.
• Tracing MBOT's Change in Cash over 5 years: stood at -$1.9 million in 2022, then jumped by 160.04% to $1.1 million in 2023, then surged by 132.04% to $2.6 million in 2024, then tumbled by 205.65% to -$2.8 million in 2025, then soared by 97.99% to -$56000.0 in 2026.
• The last three Change in Cash figures came in at -$56000.0 (Q1 2026), -$2.8 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.